NAV as on 2026-07-17 · Equity · Index
AUM
₹22 Cr
1Y Return
+9.8%
3Y CAGR
-
5Y CAGR
-
Expense
0.80%
Risk
Very High
1Y Return
+9.8%
3Y CAGR
-
5Y CAGR
-
Since Inception
+13.7%
AI Fund Analysis
Get AI-powered verdict, strengths, risks, and SIP recommendations for this fund.
NAV History
Drag or scroll the chart to pan through history
52-Week NAV Range
92% from 52W low
Fund Information
Fund House
DSP Mutual Fund
Category
Equity - Index
Min SIP
₹500
Min Lumpsum
₹5,000
Portfolio Composition
Asset Allocation
Market Cap Split
Top Holdings
Sun Pharmaceuticals Industries Ltd
Healthcare
Dr Reddy's Laboratories Ltd
Healthcare
Apollo Hospitals Enterprise Ltd
Healthcare
Divi's Laboratories Ltd
Healthcare
Max Healthcare Institute Ltd Ordinary Shares
Healthcare
Cipla Ltd
Healthcare
Lupin Ltd
Healthcare
Torrent Pharmaceuticals Ltd
Healthcare
Fortis Healthcare Ltd
Healthcare
Laurus Labs Ltd
Healthcare
Sector Allocation
Fundamentals
P/E Ratio
39.02
Cat avg: 24.50
P/B Ratio
5.30
Cat avg: 3.98
Dividend Yield
0.63%
Cat avg: 1.53%
Price/Sale
5.63
Price/Cash Flow
29.52
Peer Comparison
| Fund | AUM (Cr) | Exp % | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| DSP Nifty Healthcare Index Reg Gr | 22 | 0.80 | +9.8% | - | - |
| Groww Nifty SmCp 250MomtQul100IdxRgGr | - | 1.04 | - | - | - |
| UTI Nifty 50 Index Fund Reg Gr | 28,685 | 0.38 | -2.3% | +8.2% | +9.8% |
| HDFC Nifty 50 Index | 23,703 | 0.46 | -2.4% | +8.1% | +9.7% |
| ICICI Pru Nifty 50 Index Reg Gr | 16,839 | 0.35 | -2.4% | +8.1% | +9.7% |
| SBI Nifty Index Reg Gr | 13,646 | 0.40 | -2.4% | +8.0% | +9.6% |
| ICICI Pru Nifty Next 50 Index Gr | 9,476 | 0.59 | +4.7% | +17.3% | +12.9% |
| UTI Nifty200 Momentum 30 Index Reg Gr | 8,541 | 0.93 | -2.6% | +12.0% | +10.7% |
| HDFC BSE Sensex Index | 8,485 | 0.37 | -4.4% | +6.3% | +8.9% |
| UTI Nifty Next 50 Index Reg Gr | 7,002 | 0.84 | +4.8% | +17.4% | +12.9% |
What If I Had Invested?
NAV history not available for this range
Key Metrics
Risk-o-Meter
Low
Moderate
High
Very High
Rated as Very High risk
Disclaimer: Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. NAV data sourced from AMFI. This is not SEBI-registered investment advice.